![Charles Bisgaier](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Charles Bisgaier
Algemeen Directeur bij Genetobe LLC
Profiel
Charles Bisgaier is the founder of Genetobe LLC.
He currently works as a Director at Diapin Therapeutics LLC.
Actieve functies van Charles Bisgaier
Bedrijven | Functie | Begin |
---|---|---|
Diapin Therapeutics LLC
![]() Diapin Therapeutics LLC BiotechnologyHealth Technology Diapin Therapeutics LLC operates as a pre-seed, preclinical development-staged company .The company was founded by Yuqing Chen in 2011 and is headquartered in Ann Arbor, MI. | Directeur/Bestuurslid | - |
Genetobe LLC
![]() Genetobe LLC Packaged SoftwareTechnology Services Genetobe LLC is a genetic disease company based in Ann Arbor, MI, USA. The company's mission is to create translational genetic disease models for demonstrating preclinical efficacy. The company has preclinical and clinical stage assets with proof of concept in preclinical in vivo models. Genetobe uses a next-generation CRISPR/Cas9 platform for their technology. The management team has over 150 years of experience in drug discovery, development, registration, and commercialization that has produced multiple registered pharmaceutical products and candidates. The company was founded by Charles Bisgaier and Eugene Chen, and Charles Bisgaier has been the CEO since incorporation. | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Diapin Therapeutics LLC
![]() Diapin Therapeutics LLC BiotechnologyHealth Technology Diapin Therapeutics LLC operates as a pre-seed, preclinical development-staged company .The company was founded by Yuqing Chen in 2011 and is headquartered in Ann Arbor, MI. | Health Technology |
Genetobe LLC
![]() Genetobe LLC Packaged SoftwareTechnology Services Genetobe LLC is a genetic disease company based in Ann Arbor, MI, USA. The company's mission is to create translational genetic disease models for demonstrating preclinical efficacy. The company has preclinical and clinical stage assets with proof of concept in preclinical in vivo models. Genetobe uses a next-generation CRISPR/Cas9 platform for their technology. The management team has over 150 years of experience in drug discovery, development, registration, and commercialization that has produced multiple registered pharmaceutical products and candidates. The company was founded by Charles Bisgaier and Eugene Chen, and Charles Bisgaier has been the CEO since incorporation. | Technology Services |